Press Release: FDA approves Novartis drug Promacta(R) for first-line SAA and grants Breakthrough Therapy designation for additional new indication
Novartis International AG / FDA approves Novartis drug Promacta(R) for first-line SAA and grants Breakthrough Therapy designation for additional new indication. Processed and transmitted by West Corporation. The issuer is solely responsible …
Novartis International AG / FDA approves Novartis drug Promacta(R) for first-line SAA and grants Breakthrough Therapy designation for additional new indication. Processed and transmitted by West Corporation. The issuer is solely responsible ...